Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Govindan, R. [1 ]
Fakih, M. [2 ]
Price, T. [3 ]
Falchook, G. [4 ]
Desai, J. [5 ]
Kuo, J. [6 ]
Strickler, J. [7 ]
Krauss, J. [8 ]
Li, B. [9 ]
Denlinger, C. [10 ]
Durm, G. [11 ]
Ngang, J. [12 ]
Henary, H. [12 ]
Ngarmchamnanrith, G. [12 ]
Rasmussen, E. [12 ]
Morrow, P. K. [12 ]
Hong, D. [13 ]
机构：
[1] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Queen Elizabeth Hosp, Woodville South, Australia
[4] HealthONE, Sarah Cannon Res Inst, Denver, CO USA
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[6] Scientia Clin Res, Randwick, NSW, Australia
[7] Duke Univ, Med Ctr, Durham, NC 27706 USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[10] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[11] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[12] Amgen Inc, Thousand Oaks, CA 91320 USA
[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
AMG; 510; lung cancer; KRAS G12C; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA01.06
引用
收藏
页码：S1125 / S1126
页数：2
相关论文
共 50 条
  • [21] The next generation farnesyltransferase inhibitor, KO-2806, blocks oncogenic signaling at multiple nodes to enhance the antitumor efficacy of KRASG12C inhibitor adagrasib in KRASG12C non-small cell lung carcinoma
    Patel, Hetika V.
    Smith, Alison
    Chan, Stacia
    Kessler, Linda
    Burrows, Francis
    Malik, Shivani
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [22] WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer
    Yamamoto, Gaku
    Tanaka, Kosuke
    Kamata, Ryo
    Saito, Hitoshi
    Yamamori-Morita, Tomoko
    Nakao, Takehiro
    Liu, Jie
    Mori, Shunta
    Yagishita, Shigehiro
    Hamada, Akinobu
    Shinno, Yuki
    Yoshida, Tatsuya
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Watanabe, Shun-Ichi
    Yatabe, Yasushi
    Kitai, Hidenori
    Konno, Satoshi
    Kobayashi, Susumu S.
    Ohashi, Akihiro
    CANCER LETTERS, 2025, 611
  • [23] First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation
    De, Surya K.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (03) : 266 - 272
  • [24] A Novel Inhibitor for KRASG12C Mutant Lung Carcinoma
    Khan, H. Y.
    Li, Y.
    Aboukameel, A.
    Mpilla, G.
    Sexton, R.
    Kanbur, T.
    Cetinkaya, H.
    Cagir, A.
    Al-Hallak, M. N.
    Sukari, A.
    Azmi, A. S.
    Nagasaka, M.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S15 - S15
  • [25] Discovery and in vitro characterization of AMG 510-a potent and selective covalent small-molecule inhibitor of KRASG12C
    Saiki, Anne Y.
    Gaida, Kevin
    Rex, Karen
    Achanta, Pragathi
    San Miguel, Tisha
    Koppada, Neelima
    Bagal, Dhanashri
    Lanman, Brian A.
    Foti, Robert S.
    McCarter, John D.
    Volak, Laurie P.
    Canon, Jude
    Cee, Victor J.
    Lipford, J. Russell
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Phase I study of D-1553 to assess safety and efficacy in patients with non-small cell lung cancer (NSCLC) harboring KRASG12C mutation.
    Jian, Hong
    Song, Zhenbo
    Zhang, Yiping
    Li, Kunyan
    Yang, Nong
    Moore, Melissa
    Wang, Pingli
    Zhao, Yanqiu
    Gong, Yi
    Underhill, Craig
    Kim, Sang-We
    Yang, Cheng-Ta
    Xiang, Ziyong
    Shi, Zhe
    Zhang, Ling
    Wang, Yaolin
    Lu, Shun
    CANCER RESEARCH, 2022, 82 (12)
  • [27] VT204: A Potential Small Molecule Inhibitor Targeting KRASG12C Mutation for Therapeutic Intervention in Non-Small Cell Lung Cancer
    Yang, Xuechao
    Zhang, Shu
    Yang, Yang
    Duan, Xiaoqun
    Li, Xiaochuan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [28] In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer
    Kato, Ryoji
    Solanki, Hitendra S.
    Ozakinci, Hilal
    Desai, Bina
    Gundlapalli, Harika
    Yang, Yu Chi
    Aronchik, Ida
    Singh, Mallika
    Johnson, Joseph
    Marusyk, Andriy
    Boyle, Theresa A.
    Haura, Eric B.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1150 - 1162
  • [29] KRASG12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
    Fujimoto, Kazushi
    Ikeda, Satoshi
    Tabata, Erina
    Kaneko, Taichi
    Sagawa, Shinobu
    Yamada, Chieri
    Kumagai, Kosumi
    Fukushima, Takashi
    Haga, Sanshiro
    Watanabe, Masayuki
    Muraoka, Tatsuya
    Sekine, Akimasa
    Baba, Tomohisa
    Ogura, Takashi
    CANCERS, 2024, 16 (07)
  • [30] Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
    Jaenne, Pasi A.
    Riely, Gregory J.
    Gadgeel, Shirish M.
    Heist, Rebecca S.
    Ou, Sai-Hong I.
    Pacheco, Jose M.
    Johnson, Melissa L.
    Sabari, Joshua K.
    Leventakos, Konstantinos
    Yau, Edwin
    Bazhenova, Lyudmila
    Negrao, Marcelo V.
    Pennell, Nathan A.
    Zhang, Jun
    Anderes, Kenna
    Der-Torossian, Hirak
    Kheoh, Thian
    Velastegui, Karen
    Yan, Xiaohong
    Christensen, James G.
    Chao, Richard C.
    Spira, Alexander I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 120 - 131
12345